Neuroendocrine tumors of the pancreas are a heterogeneous group of tumors with varying
clinical presentation, tumor biology and prognosis. Clinicians must be aware of the variety of …

Well-differentiated pancreatic neuroendocrine tumors (PanNETs) comprise∼ 1–3% of
pancreatic neoplasms. Although long considered as reasonably benign lesions, PanNETs …

Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms
(NENs), the emerging results of new clinical trials, and the new guidelines issued by medical …

Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine
neoplasms (NEN), the published results of new randomised clinical trials, and the new …

Zollinger–Ellison syndrome: recent advances and controversie... : Current Opinion in
Gastroenterology Zollinger–Ellison syndrome: recent advances and controversies : Current …

Colorectal mixed adenoneuroendocrine carcinoma (MANEC), which acts like an aggressive
tumor, is a rare clinical manifestation on which only a limited amount of literature exists …

Background The latest studies on surgical and cost-analysis outcomes after laparoscopic
distal pancreatectomy (LDP) highlight mixed and insufficient results. Whereas several …

Background A number of different therapies, including endoscopic resection, have been
suggested for the treatment of Type 1 gastric neuroendocrine tumors (NETs). The current …

Gastric neuroendocrine tumors (NETs) are classified into three types. Type I gastric NETs
are associated with chronic atrophic gastritis. They have a good prognosis and endoscopic …

BACKGROUND Neuroendocrine tumors (NETs) frequently occur in the gastrointestinal tract,
lung, and pancreas, and the rectum and appendix are the sites with the highest incidence …